Information, remedies, research & more from your Homeopath

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

“The information contained in this message is for educational purposes and constitutes a response to a private request for information only and does not constitute a solicitation for services and makes no claim or promise that any product or service that may cure any condition or ailment,”

February 26, 2012

Vaccine Damage 1982 interviews with parents from DPT

February 26, 2012/ WOA Admin

[youtube http://www.youtube.com/watch?v=4fMHDq_wlE0?wmode=transparent]

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

February 26, 2012

Flu Vaccine and Guyenne Barre syndrom

February 26, 2012/ WOA Admin

[youtube http://www.youtube.com/watch?v=tpYYwkM4kxU?wmode=transparent]

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

February 21, 2012

Homeopathy during Epidemics

February 21, 2012/ WOA Admin

Did You Know?

Here are more fun anecdotes and statistics that describe the use of homeopathy for epidemics.
1. An 1813 epidemic of typhus fever (spread by lice) followed Napoleon’s army marching through Germany to attack Russia. When the epidemic came through Leipzig as the army retreated from the east, Samuel Hahnemann, the founder of homeopathy, treated 180 cases of typhus, only losing two (1.11% of the cases). This was at a time when conventional treatments were having a mortality rate of over 30%.
2. Within three years of the diphtheria outbreak in Broome County, New York, from 1862 to 1864, there was a report of an 83.6% mortality rate amongst the conventional medical doctors and a 16.4% mortality rate among the homeopaths.
3. The May 1921 edition of the Journal of the American Institute for Homeopathy had an article about the use of homeopathy during the 1918 flu epidemic. Dr. T. A. McCann, from Dayton, Ohio, reported that 24,000 cases of flu treated with conventional medicine had a mortality rate of 28.2% while 26,000 cases of flu treated homeopathically had a mortality rate of 1.05%.
Just watch the contemporary film, 'Contagion' and see!

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

info@accessnaturalhealing.com

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

February 20, 2012

n late 2011, the Swiss government's report on homeopathic medicine represents the most comprehensive evaluation of homeopathic medicine ever written by a government

February 20, 2012/ WOA Admin

The Swiss government has a long and widely-respected history of neutrality, and therefore, reports from this government on controversial subjects need to be taken more seriously than other reports from countries that are more strongly influenced by present economic and political constituencies. When one considers that two of the top five largest drug companies in the world have their headquarters in Switzerland, one might assume that this country would have a heavy interest in and bias toward conventional medicine, but such assumptions would be wrong. In late 2011, the Swiss government's report on homeopathic medicine represents the most comprehensive evaluation of homeopathic medicine ever written by a government and was just published in book form in English (Bornhoft and Matthiessen, 2011). This breakthrough report affirmed that homeopathic treatment is both effective and cost-effective and that homeopathic treatment should be reimbursed by Switzerland's national health insurance program.

The Swiss government's inquiry into homeopathy and complementary and alternative (CAM) treatments resulted from the high demand and widespread use of alternatives to conventional medicine in Switzerland, not only from consumers but from physicians as well. Approximately half of the Swiss population have used CAM treatments and value them. Further, about half of Swiss physicians consider CAM treatments to be effective. Perhaps most significantly, 85 percent of the Swiss population wants CAM therapies to be a part of their country's health insurance program.

It is therefore not surprising that more than 50 percent of the Swiss population surveyed prefer a hospital that provides CAM treatments rather to one that is limited to conventional medical care.

Beginning in 1998, the government of Switzerland decided to broaden its national health insurance to include certain complementary and alternative medicines, including homeopathic medicine, traditional Chinese medicine, herbal medicine, anthroposophic medicine, and neural therapy. This reimbursement was provisional while the Swiss government commissioned an extensive study on these treatments to determine if they were effective and cost-effective. The provisional reimbursement for these alternative treatments ended in 2005, but as a result of this new study, the Swiss government's health insurance program once again began to reimburse for homeopathy and select alternative treatments. In fact, as a result of a national referendum in which more than two-thirds of voters supported the inclusion of homeopathic and select alternative medicines in Switzerland's national health care insurance program, the field of complementary and alternative medicine has become a part of this government's constitution (Dacey, 2009; Rist, Schwabl, 2009).

The Swiss Government's "Health Technology Assessment"

The Swiss government's "Health Technology Assessment" on homeopathic medicine is much more comprehensive than any previous governmental report written on this subject to date. Not only did this report carefully and comprehensively review the body of evidence from randomized double-blind and placebo controlled clinical trials testing homeopathic medicines, they also evaluated the "real world effectiveness" as well as safety and cost-effectiveness. The report also conducted a highly-comprehensive review of the wide body of preclinical research (fundamental physio-chemical research, botanical studies, animal studies, and in vitro studies with human cells).

And still further, this report evaluated systematic reviews and meta-analyses, outcome studies, and epidemiological research. This wide review carefully evaluated the studies conducted, both in terms of quality of design and execution (called "internal validity") and how appropriate each was for the way that homeopathy is commonly practiced (called "external validity"). The subject of external validity is of special importance because some scientists and physicians conduct research on homeopathy with little or no understanding of this type of medicine (some studies tested a homeopathic medicine that is rarely used for the condition tested, while others utilized medicines not commonly indicated for specific patients). When such studies inevitably showed that the homeopathic medicine did not "work," the real and accurate assessment must be that the studies were set up to disprove homeopathy... or simply, the study was an exploratory trial that sought to evaluate the results of a new treatment (exploratory trials of this nature are not meant to prove or disprove the system of homeopathy but only to evaluate that specific treatment for a person with a specific condition).

After assessing pre-clinical basic research and the high quality clinical studies, the Swiss report affirmed that homeopathic high-potencies seem to induce regulatory effects (e.g., balancing or normalizing effects) and specific changes in cells or living organisms. The report also reported that 20 of the 22 systematic reviews of clinical research testing homeopathic medicines detected at least a trend in favor of homeopathy.* (Bornhöft, Wolf, von Ammon, et al, 2006)

The Swiss report found a particularly strong body of evidence to support the homeopathic treatment of Upper Respiratory Tract Infections and Respiratory Allergies. The report cited 29 studies in "Upper Respiratory Tract Infections/AllergicReactions," of which 24 studies found a positive result in favor of homeopathy. Further, six out of seven controlled studies that compared homeopathic treatment with conventional medical treatment showed that homeopathy to be more effective than conventional medical interventions (the one other trial found homeopathic treatment to be equivalent to conventional medical treatment). All of these results from homeopathic treatment came without the side effects common to conventional drug treatment. In evaluating only the randomized placebo controlled trials, 12 out of 16 studies showed a positive result in favor of homeopathy.

The authors of the Swiss government's report acknowledge that a part of the overall review of research included one review of clinical research in homeopathy (Shang, et al, 2005). However, the authors noted that this review of research has been widely and harshly criticized by both advocates and non-advocates of homeopathy. The Swiss report noted that the Shang team did not even adhere to the QUORUM guidelines which are widely recognized standards for scientific reporting (Linde, Jonas, 2005). The Shang team initially evaluated 110 homeopathic clinical trials and then sought to compare them with a matching 110 conventional medical trials. Shang and his team determined that there were 22 "high quality" homeopathic studies but only nine "high quality" conventional medical studies. Rather than compare these high quality trials (which would have shown a positive result for homeopathy), the Shang team created criteria to ignore a majority of high quality homeopathic studies, thereby trumping up support for their original hypothesis and bias that homeopathic medicines may not be effective (Lüdtke, Rutten, 2008).

The Swiss report also notes that David Sackett, M.D., the Canadian physician who is widely considered to be one of the leading pioneers in "evidence based medicine," has expressed serious concern about those researchers and physicians who consider randomized and double-blind trials as the only means to determine whether a treatment is effective or not. To make this assertion, one would have to acknowledge that virtually all surgical procedures were "unscientific" or "unproven" because so few have undergone randomized double-blind trials.

In my view, for a treatment to be determined to be "effective" or "scientifically proven," a much more comprehensive assessment of what works and doesn't is required. Ultimately, the Swiss government's report on homeopathy represents an evaluation of homeopathy that included an assessment of randomized double blind trials as well as other bodies of evidence, all of which together lead the report to determine that homeopathic medicines are indeed effective.

The next article will discuss further evidence provided in this report from the Swiss government on the effectiveness and cost-effectiveness of homeopathic care.

--- REFERENCES:

Bornhoft, Gudrun, and Matthiessen, Peter F. Homeopathy in Healthcare: Effectiveness, Appropriateness, Safety, Costs. Goslar, Germany: Springer, 2011. http://rd.springer.com/book/10.1007/978-3-642-20638-2/page/1(This book is presently available from the German office of the publisher, and it will become available via the American office as well as select booksellers in mid- to late-February, 2012.)(NOTE: When specific facts in the above article are provided but not referenced, this means that these facts were derived from this book.)

Bornhöft G, Wolf U, von Ammon K, Righetti M, Maxion-Bergemann S, Baumgartner S, Thurneysen AE, Matthiessen PF. Effectiveness, safety and cost-effectiveness of homeopathy in general practice - summarized health technology assessment. Forschende Komplementärmedizin (2006);13 Suppl 2:19-29. http://www.ncbi.nlm.nih.gov/pubmed/16883077

Dacey, Jessica. Therapy supporters roll up sleeves after vote. SwissInfo.ch, May 19, 2009. http://www.swissinfo.ch/eng/politics/Therapy_supporters_roll_up_sleeves_after_vote.html?cid=670064

Linde K, Jonas W. Are the clinical effects of homeopathy placebo effects? Lancet 36:2081-2082. DOI:10.1016/S0140-6736(05)67878-6. http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673605678786.pdf

Lüdtke R, Rutten ALB. The conclusions on the effectiveness of homeopathy highly depend on the set of analysed trials. Journal of Clinical Epidemiology. October 2008. doi: 10.1016/j.jclinepi.2008.06/015. http://www.jclinepi.com/article/S0895-4356(08)00190-X/abstract

Rist L, Schwabl H: Komplementärmedizin im politischen Prozess. Schweizer Bevölkerungstimmt über Verfassungsartikel «Zukunft mit Komplementärmedizin» ab. Forsch Komplementmed 2009, doi 10.1159/000203073. (Translation: Complementary medicine in the political process: The Swiss population votes on the Constitutional Article "The future with complementary medicine" http://www.ayurveda-association.eu/files/swiss_referendum_on_cam_-_forschkomplementmed_2009.pdf

*Although this Swiss government report was just published in book form in 2011, the report was finalized in 2006. In light of this date, the authors evaluated systematic reviews and meta-analyses on homeopathic research up until June 2003.

By, Dana Ullman, MPH, is America's leading spokesperson for homeopathy and is the founder of www.homeopathic.com. He is the author of 10 books, including his bestseller, Everybody's Guide to Homeopathic Medicines. His most recent book is, The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy (the Foreword to this book was written by Dr. Peter Fisher, the Physician to Her Majesty Queen Elizabeth II). Dana lives, practices, and writes from Berkeley, California.

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

February 16, 2012

[Fwd: [HOMEOPATHY] Who is more neutral than the Swiss...]

February 16, 2012/ WOA Admin

Dana Ullman posted in HOMEOPATHY.

Dana Ullman

6:40am Feb 15

Who is more neutral than the Swiss government...and this is the most positive report on homeopathy ever published by a government! This is great news...spread the good news! http://www.huffingtonpost.com/dana-ullman/homeopathic-medicine-_b_1258607.html?ref=health-and-fitness&ir=Health+and+Fitness

The Swiss Government's Remarkable Report on Homeopathic Medicine

www.huffingtonpost.com

The Swiss government's report on homeopathic medicine represents the most comprehensive evaluation o...

View Post on Facebook · Edit Email Settings · Reply to this email to add a comment.

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

February 12, 2012

How Safe Is Universal Hepatitis B Vaccination? by Burton A. Waisbren, Sr., M.D., F.A.C.P.

February 12, 2012/ WOA Admin

How Safe Is Universal Hepatitis B Vaccination? by Burton A. Waisbren, Sr., M.D., F.A.C.P.

http://www.waisbrenclinic.com

INTRODUCTION Universal hepatitis B vaccination of infants in the United States, regardless of risk factors, was first proposed by Margolis and his coworkers of the hepatitis branch of the Center for Disease Control and Prevention in Atlanta, Georgia.(1,2) The concept was endorsed and augmented by West and his coworkers at the Merck Sharpe and Dohme research laboratories in West Point, Pennsylvania.(3) The rationale presented for universal vaccination of infants in the U.S. stemmed from the failure of the current strategies for controlling this disease and not from trials that demonstrated the effectiveness or safety of a universal hepatitis B vaccination program.(4,5) In spite of this, universal hepatitis B vaccination is achieving wide spread acceptance among medical organizations and is being vigorously pursued in many sections of the country.(5,6)

To be presented here are four patterns that raise some concerns about vaccinating all babies in the U.S. with the hepatitis B vaccine. The patterns are as follows: The historical pattern of events that followed the introduction of an antirabies vaccine in the late 1800's and of warnings regarding probable occurrence of vaccine complications given by medical scientists during the past 50 years; the pattern revealed by animal experimentation that showed that viruses and viral particles may cause demyelination and autoimmunity in a variety of species; the pattern of autoimmunity and demyelination that has been caused by the hepatitis B infection, itself; the pattern of clinical reports that reveal that demyelination and autoimmunity have appeared in patients vaccinated with hepatitis B vaccines.

Reasonable steps that might be taken to address the concerns evoked by the above patterns will be discussed.

--------------------------------------------------------

Postvaccinal Encephalomyelitis and Warnings by Medical Scientists

Postvaccinal encephalomyelitis has been recognized and accepted as a clinical entity since it first occurred after Pasteur's antirabies vaccine was used. (7) At first the encephalomyelitis was thought to be caused by the nervous tissue in which the virus used for the vaccine was grown. (7) However, postvaccinal encephalomyelitis has appeared in patients who received vaccine grown in duck eggs, so it is now thought that the syndrome is caused by something present in the dead virus.(8) Postvaccinal encephalomyelitis has since been observed after a wide variety of vaccinations.

Within the past 30 years representatives of the medical establishment have discussed and warned about neurologic complications of various vaccines. (9-12) Wilson, in his 1967 monograph regarding vaccine complications, pointed out that there are no insurance policies without premiums and that strict attention must be paid to the premiums exacted by each vaccine.(9) Miller, in 1954, discussed the neurologic sequelae of vaccination and the difficulty of these complications being recognized and accepted. (10) Zuckerman, in an article in 1974 in Nature entitled "Hepatitis Vaccine: A note of caution" pointed out that autoimmunity might well follow the hepatitis B vaccinations because the disease, itself, involved autoimmunity.(11) He suggested, "careful assessment of all vaccine effects on the immune system."(11) As late as 1988, Hilleman, who some call the "father" of hepatitis B vaccine, warned "the message from the hypothetical hepatitis B example is that the administration of antigens or monoclonal antibodies that directly or indirectly raise antibodies that attach to host cell receptors may carry large liabilities even though they might provide a convenient means for preventing viral access to host cells... antibodies attached to cell receptors may invite the same kinds of adverse response that are believed to be responsible for a variety of autoimmune disorders." (12)

Experiments In Animals That Lead To Concerns about the Hepatitis B Vaccine

Experiments done on animals in the past 60 years have yielded data that add to the concerns about present day viral vaccines. These experiments have shown that polypeptide chains of the types found in viruses that are homologous or nearly homologous with myelin can cause demyelination and have shown that viruses, themselves, can cause demyelination.(13)

The experiments started in 1956 when Rivers showed that myelin injected into monkeys caused demyelination.(14) Wakesman expanded these studies and developed an experimental model in which myelin and adjuvant consistently caused demyelinating disease in mice and rabbits.(15) This has been widely accepted as a model for demyelinating diseases in humans and is called experimental allergic encephalomyelitis (EAE). (16) Stohlman found that a DNA virus called JHM could cause demyelination in mice. (17) Oldstone then presented experimental evidence that autoimmunity in humans was caused by polypeptides in viruses that were homologous to those in human tissue. (18) Fujinami and Oldstone produced EAE in rabbits with proteins from hepatitis B virus that had polypeptides in it that were homologous with myelin.(19) Ziegler produced EAE in rabbits with the Swine Flu Vaccine and adjuvants.(20)

Westall and Root-Bernstein presented data that suggested a syndrome they called Multiple-Antigen-Mediated-Autoimmunity (MAMA) could occur in animals and humans. (21) They postulated that the MAMA Syndrome was operative in postvaccinal encephalomyelitis as well as in EAE.(21) Root-Bernstein hypothesized that this syndrome could occur in humans if four conditions were met. The first was demonstrated homology between an antigen and host tissue. The second was the presence simultaneously, of more than one antigen. The third was complementarity between the antigens shown to be present. The fourth was the additional presence of a bacterial adjuvant. As will be discussed later, all of these requirements can be tested for as a possible explanation for post hepatitis B vaccine reactions.

Finally, the HLA patterns of experimental animals has been shown to influence their susceptibility to experimental demyelinating diseases.(22)

Hepatitis B Infection Causes Autoimmunity and Demyelination

Another group of patterns regarding the consideration of universal hepatitis vaccination, without factoring in risk factors that have been largely ignored, are those revealed by the findings that the infection, itself, causes autoimmunity and demyelination. In 1977, London first reported that autoimmune disease was caused by circulating immune complexes caused by viral antibody association.(23) In 1987, Tsukada reported demyelinizing neuropathy associated with the hepatitis B infection.(24) Discussions and case reports regarding autoimmunity occurring with the hepatitis B infection have been presented by Vento et al and McFarlane et al.(25,26) As early as 1976, Zuckerman cautioned that since autoimmunity is involved in the pathogenesis of hepatitis B infections that it might be augmented by a hepatitis B vaccination.(11)

Reports Of Demyelination and Autoimmunity After Hepatitis B Vaccination

Clinical experiences since the general release of hepatitis B vaccines suggest that clinical counterparts of the animal studies and autoimmunity that occurs after the hepatitis B infection occur after hepatitis B vaccination. The first report of demyelination after the hepatitis B vaccination was that of Ribera and Dutka in 1983. The complication was transient.(27) The authors stated inflammatory polyradiculoneuropathies after both viral diseases and vaccinations have been widely reported.(27) They emphasized the necessity of continued surveillance of the use of hepatitis B vaccine.(27) I have noted seven cases of a neurologic picture resembling multiple sclerosis (MS) after hepatitis B vaccination. (28) In 1987, Fried et al reported uveitis that occurred in a 20-year-old nurse after a booster dose of hepatitis B vaccine.(29) They pointed out that there is a higher than normal level of hepatitis B antibodies in some uveitis patients. They postulated that these antibodies combined with surface antigens in the vaccine could form a disease producing immune complex.(29)

Shaw et al reported a post marketing surveillance study regarding neurologic events after the hepatitis B vaccine in 1988. (30) An estimated 850,000 individuals had received the vaccine by the time of their study. They found ten cases of Bell's palsy, nine cases of Guillain-Barre Syndrome, five cases of lumbar radiculopathy, three cases of brachial plexus neuropathy, five cases of optic neuritis, and four cases of transverse myelitis. They concluded, on the basis of the controversial epidemiologic methods used to study the Swine Flu epidemic of 1976, that the risk of the vaccine was outweighed by the prophylactic benefits in "high risk groups."(30,31) However, even using these methods, they concluded that the demyelinating disease, Guillain-Barre Syndrome, occurred more often in individuals who had been vaccinated than in the general population.(30) In 1988, Biron et al reported a case of myasthenia gravis that occurred after anesthesia and a hepatitis B vaccination.(32) They postulated that the autoimmune disease was due to the "challenge" to the immune system by the vaccine.(32) In 1989, Goolsby reported a case of erythema nodosum that occurred after recombinant hepatitis B vaccine. (33) In 1991, Herroelen et al reported on two patients who developed symptoms of increasing demyelination after a vaccination of recombinant hepatitis B vaccine. (34) He mentioned that their HLA patterns might be a contributing factor. Seven hundred reports of adverse reactions to the hepatitis B vaccine were sent in to the Vaccine Adverse Events Reporting Systems (VAERS) between October 1990 and September 1991.(35) This system was set up via the National Childhood Vaccine Injury Act of 1986. Sixteen percent of these reports were of damage presumed to be to the myelin of the nervous system. There were 21 cases of facial paralysis and six cases of MS. Eighty-two of the complications occurred in patients who received plasma derived vaccine and 18 occurred in those who received recombinant vaccine. (35) This difference can be explained by the fact that at the time the VAERS were examined, the recombinant vaccine had just come into general use. In 1990, in the World Health Organization Drug Information Bulletin two cases of optic neuritis and one case of Guillain-Barre Syndrome were reported to be among the 200 reports of adverse reactions that were reported by the Australian National Regulatory Body. (36) One patient had vertigo and diplopia attributed to demyelination eight months after the vaccination.(36)

In 1993, Trevisani et al reported a case of transverse myelitis that followed a recombinant vaccination in an 11 year-old girl.(37) Their arguments for a causal link between the vaccination and the transverse myelitis were the temporal association (21 days), the previous report of Shaw's in which the same complication occurred, and no clinical evidence of any other cause of the disease.(37) They pointed out that transverse myelitis was occasionally found in patients with hepatitis B. (37) This suggested to them that there might be antigenic determinants held in common with the capsular antigen of the hepatitis B vaccine and myelin.(37)

In 1993, Nadler et al reported a case of "classic MS," the prodromal of which appeared 10 days after a recombinant vaccination. (38) They stated that the benefits of the hepatitis B vaccination, among the population for "which it is usually recommended," far out weigh any potential risks.(38) In 1990, there was a report in the British Medical Journal of vasculitis related to the hepatitis B vaccination.(39) It was felt to be due to immune complex disease. In 1993, Brezin et al reported visual loss and eosinophilia after a recombinant hepatitis B vaccine.(40)

In 1995, Kaplanski et al reported a case of central nervous system demyelination that occurred in a 37-year-old man two weeks after receiving the third hepatitis B injection.(41) This patient had the same haplotype as the patient reported by Herroelen.(34) They suggested that the hepatitis B vaccination could potentially induce CNS demyelination in patients with HLA, B7, DR2 haplotype, whether or not these patients have a history of MS.(41)

Vautier and Carty in 1994 reported a case of classic rheumatoid arthritis that followed a hepatitis B vaccination.(42) They brought up the fact that the patient was HLA, DR4 positive which would be consistent with both animal and previous clinical reports regarding complications of the hepatitis B vaccine.(22,33,42) Hassan and Oldham reported two cases of reactive arthritis and Reiter's Syndrome that occurred after a recombinant hepatitis B vaccine.(43) They cite a personal communication from the manufacturer that stated that in 11 cases reported to them of reactive arthritis following recombinant hepatitis B vaccine that six had a recurrence of symptoms after a second vaccination.(43)

In 1995, Tartaglina et al reported a case of postvaccinal myelitis that occurred one month after a hepatitis B vaccination.. (44) They suggested that complications of this sort may be under reported because there can be a delay in symptom occurrences.(44) In the case they reported, symptoms did not occur until one month after a single injection of the vaccine. No other cause of the myelitis was shown by a MRI.(44)

DISCUSSION

How might the concerns evoked by the material that has been presented be addressed?

Parents of babies and adolescents who have little chance of being exposed to hepatitis B should be made aware of the potential dangers of the vaccine. A perspective, inclusive, long term follow up study of a large number of individuals who have received the vaccine should be done and the results should be made available to the parents of children who are to be vaccinated. While these admittedly tedious studies are being conducted, databases available through societies such as the Multiple Sclerosis Society might be used to determine if an inordinate number of patients with multiple sclerosis had received a hepatitis B vaccination prior to being diagnosed.

The literally hundreds of individuals who have been reported to VAERS and pharmaceutical companies, who claim to have suffered demyelination and autoimmunity from a hepatitis B vaccine, should be followed up to determine their HLA patterns to ascertain if host factors are partially causative of the complication.(22,33)

A large group of individuals who are to be vaccinated should have before and after determinations by the methods of Zhang, Wucherpfennig and Strominger of the percentage of their T-cells that exhibit antimyelin activity to determine if vaccination does evoke such cells in some individuals with certain HLA patterns.(47,48)

The ability of vaccines when injected with adjuvant into animals to cause EAE should be tested using the methods of Fujinami and Ziegler.(19,20)

The hypothesis and studies of Westall and Root-Bernstein that indicate a multifactorial pathogenesis of postvaccinal encephalomyelitis suggest a series of studies that could be done on vaccines and on patients who developed complications after the hepatitis B vaccination.(21) Hepatitis B vaccine and all other vaccines should be tested for the extent of their polypeptide homology with human tissue.(13,21) If significant homology were to be demonstrated, the offending polypeptides could be removed from the vaccine or synthetic vaccines could be produced without them. (49,50) If such a homology were to be demonstrated, it would fulfill the first requirement for the provocative hypothetical MAMA Syndrome of Westall and Root-Bernstein. (21) The second requirement for the MAMA Syndrome is that multiple antigens are present.(21) These could be tested for by serologic studies for the Epstein-Barr Virus and other viruses that already have been indicted in this syndrome.(21) The third requirement that complementarity between antigens must be demonstrated could be tested for by complementarity studies between the hepatitis B vaccine and other antigens uncovered by the aforementioned serologic tests. (51) The fourth requirement that an adjuvant be present could be tested for by serologically determining whether muramyl peptides are present. (52) These peptides are well established adjuvants and are ubiquitous as part of the cell walls of all bacteria.(52)

The above-mentioned studies might well yield information that would not only make all vaccines safer, but could lead to means to prevent postvaccinal autoimmunity by the methods shown to work in animals by Westall and Root-Bernstein and Norga et al.(53,54)

Finally, it should be emphasized that the concerns voiced above in no way denigrate worldwide programs that are attempting to reduce hepatitis B in populations of extremely high risk, both internationally and in the U.S.(55) Certainly, there should be no abrupt stopping of present vaccination programs in the U.S., but it does seem reasonable to develop an informed consent that discloses to parents the potential dangers of the vaccine. Parents then would be able to intelligently decide whether the risk involved justifies their child receiving the vaccination. This might be particularly reasonable in areas of the U.S. in which the incidence of hepatitis B is very low.

February 08, 2012

Meningococcal Meningitis in Brazil

February 08, 2012/ WOA Admin

The Brazilian ExperienceIn 1998 there was an outbreak of meningococcal meningitis in a region of Brazil. Many doctors in that country are also homeopaths. There was no vaccine available at the time, so a group of doctors who worked in the region used the meningococcal Nosode to immunize 65,826 children. Another 23,539 children in the region were not immunized. The doctors followed the two groups for 12 months. After 6 months the efficacy of homeoprophylaxis was 95%, and after 12 months was 91%. A complete and statistically rigorous report was published in a leading peer reviewed Homeopathic journal, and is available for study (see reference following). Mroninski C, Adriano E, Mattos G (2001) Meningococcinum: Its protective effect against meningococcal disease. Homoeopathic Links Winter Vol 14(4); pp. 230-4.

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

January 27, 2012

ABC News Doc Recommends Homeopathy for Stomach Viruses

January 27, 2012/ WOA Admin

ABC News Doc Recommends Homeopathy for Stomach Viruses January 26, 2012 by Peter Filed under Blog, Flu, Homeopathy In The News, Parents Guide to Children's Health

ABC News doc - Dr. Albert Levy M.D. just did a story for ABC on stomach viruses. Eli Manning of the New York Giants recently had a bad stomach virus - so ABC wanted to share treatment options with their viewers. In the piece, viewable at the link below, Dr. Albert Levy M.D. recommends homeopathic remedies for these viruses. Good piece. Check it out!

And if you want to learn how to treat stomach bugs and other acute conditions like earaches, sore throats, coughs, flu and more - consider becoming a member of the National Center for Homeopathy.

(http://www.nationalcenterforhomeopathy.org/member-benefits/)

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

info@accessnaturalhealing.com

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter:

http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top

LinkedIn:

January 12, 2012

Homeopathy Halts Cuban Epidemic Better Than Vaccines

January 12, 2012/ WOA Admin

Homeopathy Halts Cuban Epidemic Better Than Vaccines Swamp fever, also known as leptospirosis, is a major problem in Cuba. Each year, an epidemic of swamp fever plagues the island nation during the flood season when the illness is transferred from rats to people.

The very serious symptoms of swamp fever include fever, diarrhea, vomiting, jaundice, meningitis, liver failure, renal damage, respiratory illness and in many cases, death.

Fortunately for Cuba, Big Pharma is not much interested in monopoly control of its healthcare system which leaves the door open for alternative and nontoxic approaches to health to bloom.

In this environment very open to homeopathy, the Finlay Institute, a Cuban research foundation, worked with Cuban doctors to develop a homeopathic nosode for swamp fever.

The remedy was based on the homeopathic principle that “like cures like” and was developed and administered on a wide scale as a preventative treatment. In 2008, 2.5 million people who were most susceptible to the disease were treated with 2 doses of the remedy seven to nine days apart. The Cuban Ministry of Public Health implemented and managed the operation.

The results of this effort were nothing short of spectacular. The typical rate of infection when vaccination and antibiotics are used is a few thousand cases per year including some deaths.

When the homeopathic remedy was used, however, only ten cases of swamp fever were reported among the 2.5 million treated with the homeopathic nosode with no mortality of any hospitalized patients!

The financial cost to the Cuban government for this astonishingly successful health campaign was only $200,000 compared with the $2,000,000 that would have been incurred for conventional vaccination and antibiotics.

Not only was homeopathy clearly more effective than vaccines for preventing swamp fever, it was also a much more cost effective solution with no toxic side effects such as is the case with vaccination.

Homeopathy for epidemics works. There is no need for toxic and expensive vaccine injections which produce masses of auto-immune compromised children and adults alike in need and dependent upon – more drugs!

The catalyst for widespread use of homeopathic nosodes as a safe and effective alternative to the ever growing list of toxic vaccines must come from parents, in particular mothers. Mothers must refuse toxic vaccines for their children and demand this type of safe and effective remedy at a grassroots level as it will never come from the conventional medical establishment which has a strongly invested profit motive for keeping things the way they are.

Sarah, The Healthy Home Economist

http://www.thehealthyhomeeconomist.com/homeopathy-halts-cuban-epidemic-better-than-vaccines/

Your Wellness Team at

~Access Natural Healing Centre~

604-568-4663

info@accessnaturalhealing.com

http://www.facebook.com/homeopath#!/AccessNaturalHealing

Facebook:

Twitter: